Suvorexant Recruiting Phase 4 Trials for Depression / Major Depressive Disorder (MDD) / Sleeplessness Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02729714A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
NCT02669030A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
NCT03034018Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia